INHIBITOR OF ATR (ATAXIA TELANGIECTASIA AND RAD 3 RELATED) KINASE

被引：0
|
作者：
Plummer, E. R. [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase
    Fontana, E.
    Lee, E.
    Rosen, E.
    Spigel, D.
    Hojgaard, M.
    Lheureux, S.
    Mettu, N. B.
    Carter, L.
    Plummer, R.
    Manley, P.
    Ulanet, D.
    Rimkunas, V.
    Silverman, I. M.
    O'Connell, J.
    McDougall, R.
    Wainszelbaum, M.
    Xu, Y.
    Koehler, M.
    Fretland, A. J.
    Yap, T. A.
    ANNALS OF ONCOLOGY, 2022, 33 : S3 - S4
  • [22] Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo
    Bin, Huachao
    Chen, Pei
    Wu, Ming
    Wang, Falu
    Lin, Guifeng
    Pan, Shulei
    Liu, Jingming
    Mu, Bo
    Nan, Jinshan
    Huang, Qiao
    Li, Linli
    Yang, Shengyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 232
  • [23] Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
    Al-Subhi, Nouf
    Ali, Reem
    Abdel-Fatah, Tarek
    Moseley, Paul M.
    Chan, Stephen Y. T.
    Green, Andrew R.
    Ellis, Ian O.
    Rakha, Emad A.
    Madhusudan, Srinivasan
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (02) : 277 - 286
  • [24] Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy
    Nouf Al-Subhi
    Reem Ali
    Tarek Abdel-Fatah
    Paul M. Moseley
    Stephen Y. T. Chan
    Andrew R. Green
    Ian O. Ellis
    Emad A. Rakha
    Srinivasan Madhusudan
    Breast Cancer Research and Treatment, 2018, 169 : 277 - 286
  • [25] The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 overcomes cisplatin resistance in bladder cancer
    Isono, Makoto
    Sato, Akinori
    Okubo, Kazuki
    Asano, Takako
    Torigoe, Toshihiko
    CANCER SCIENCE, 2021, 112 : 840 - 840
  • [26] The ataxia telangiectasia and Rad3-related kinase inhibitor AZD6738 sensitizes bladder cancer cells to gemcitabine
    Isono, Makoto
    Sato, Akinori
    Okubo, Kazuki
    Asano, Takako
    Asano, Tomohiko
    CANCER SCIENCE, 2018, 109 : 844 - 844
  • [27] Ataxia-telangiectasia and Rad3-related (ATR) phosphorylation as a pharmacodynamic biomarker of ATR activation in solid tumor tissue models
    Wilsker, Deborah
    Marrero, Allison M.
    Dull, Angie
    Pfister, Thomas D.
    Lawrence, Scott M.
    Carter, John
    Gottholm-Ahalt, Michelle
    Hollingshead, Melinda
    Doroshow, James
    Parchment, Ralph E.
    Kinders, Robert J.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [28] Discovery of Thieno[3,2-d]pyrimidine derivatives as potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) kinase
    Duan, Yunxin
    Cheng, Haodong
    Zhuang, Lili
    Xia, Jiawei
    Xu, Yerong
    Zhang, Ruyue
    Sun, Rui
    Lu, Tao
    Chen, Yadong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 255
  • [29] BAY1895344, a novel ataxia telangiectasia and RAD3-related (ATR) inhibitor, is active in vivo against ATRX mutated uterine leiomyosarcoma
    Harold, Justin
    Manavella, Diego
    Bellone, Stefania
    Siegel, Eric
    Mauricio, Dennis
    Hartwich, Tobias
    Zammataro, Luca Arrigo
    Mutlu, Levent
    AlAshqar, Abdelrahman
    Altwerger, Gary
    Menderes, Gulden
    Ratner, Elena
    Huang, Gloria
    Clark, Mitchell
    Andikyan, Vaagn
    Azodi, Masoud
    Schwartz, Peter
    Alexandrov, Ludmil
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S118 - S118
  • [30] First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors
    Yap, Timothy A.
    Tan, David S. P.
    Terbuch, Angelika
    Caldwell, Reece
    Guo, Christina
    Goh, Boon Cher
    Heong, Valerie
    Haris, Noor R. Md
    Bashir, Saira
    Drew, Yvette
    Hong, David S.
    Meric-Bernstam, Funda
    Wilkinson, Gary
    Hreiki, Joseph
    Wengner, Antje M.
    Bladt, Friedhelm
    Schlicker, Andreas
    Ludwig, Matthias
    Zhou, Yinghui
    Liu, Li
    Bordia, Sonal
    Plummer, Ruth
    Lagkadinou, Eleni
    de Bono, Johann S.
    CANCER DISCOVERY, 2021, 11 (01) : 80 - 91
12345